Focusing on consumer experience is no longer a marketing maybe for payers; it is increasingly a business imperative.

Head of Health & Life Sciences, North America, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts

Most payer-provider partnerships are still in the test-and-learn phase – adapting their approaches based on local market conditions and stakeholder objectives. However, some key takeaways have emerged.

Head of Health & Life Sciences, North America, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Insights into how Blue plans can navigate current market pressures and chart a successful path forward.

Head of Health & Life Sciences, North America, Oliver Wyman
Global Head, Health Services, Oliver Wyman

UnitedHealth Group's recent exit from government-organized health insurance exchanges highlights continued challenges in the ACA Marketplace.

Head of Health & Life Sciences, North America, Oliver Wyman
Principal, Oliver Wyman

Price transparency takes center stage in 2016 as plans invest in user-friendly price tools and consumers incorporate cost information into healthcare decisions.

Head of Health & Life Sciences, North America, Oliver Wyman

Insights in your inbox

Subscribe

Is like-like consolidation a good thing? Is it sufficient to create real value? We make the case that this approach is too cautious over the long term.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Head of Health & Life Sciences, North America, Oliver Wyman

In a recent AIS webinar, Oliver Wyman’s Health Services lead Todd Van Tol presented “Insurer Strategies for Large Groups.” In his presentation he explores how the healthcare insurance market is evolving, noting that by 2018 one in three Americans are expected to be buying a different insurance product than they do today, through a channel that didn’t exist three years ago, receiving 30% of their care outside of a traditional health system.

Head of Health & Life Sciences, North America, Oliver Wyman

Powerful new consumer tools are shedding light on previously hidden service costs and quality outcomes in healthcare. Yet, a closer look reveals that transparency solutions may have unintended, less-than-favorable consequences for consumers.

Head of Health & Life Sciences, North America, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman